Rivaroxaban

Details

Files

Generic Name:

Rivaroxaban

Project Status:

Complete

Therapeutic Area:

Venous thromboembolic events, pulmonary embolism

Manufacturer:

Bayer Inc.

Call for patient/clinician input open:

April 5, 2013

Brand Name:

Xarelto

Project Line:

Reimbursement Review

Project Number:

SR0327-000

Call for patient/clinician input closed:

May 27, 2013

Submission Type:

Initial

Indications:

Thromboembolic events (venous), pulmonary embolism

Recommendation Type:

List with criteria/condition

Final Recommendation:

March 26, 2014

Last Updated : May 6, 2013